MCC approves pill that can prevent sexual transmission of HIV
The drug has a 100 percent success rate but has been widely criticised around the world.
JOHANNESBURG - The Gauteng Health Department has confirmed the Medicines Control Council (MCC) has approved a pill that can stop HIV infection, for use as a preventative treatment in South Africa.
The medicine has a success rate of up to 100 percent, but has also been widely criticised globally.
There are concerns in some quarters that it may promote unsafe sex and promiscuity.
In 2013 Aspen applied for the drug, Truvada, to be used as a preventative measure, but the MCC took two years to approve it.
The department's Joe Maila says the pill will only be prescribed with strict conditions.
"The applicant must implement a risk management plan, which requires the applicants to provide prescribers with a detailed information package, together with data on adverse and report to the MCC at six months intervals."